Portal de recerca
ENSAYO DE DOSIS MÚLTIPLES PARA DETERMINAR EL INTERVALO, LA ESCALADA DE DOSIS Y LA EFICACIA DE SEMAGLUTIDA ORAL EN PACIENTES CON DIABETES TIPO 2.
Dades bàsiques
- Protocol:
- NN9924-3790
- EURDRACT:
- 2012-004994-16
- NCT:
- Centre:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Any inici:
- 2014
- Any de finalització:
- 2014
Objectius del projecte
Observaciones: Estado Comité: FINALIZADO
Documents
- No hi ha documents
Participants
Grups d'Investigació
Finançadors - Promotors
Resultats de l'Assaig Clínic
Analisis de las causas de suspension de tratamiento con triple terapia antiviral en pacientes con hepatitis C.
Ruiz Ramos J; (...); Poveda Andrés JL
Abstract of Published Item. 10.7399/fh.2014.38.3.1171. 2014
Anidulafungin-Induced Alopecia
Ruiz-Ramos J; (...); Poveda-Andrés JL
Article. 10.1177/1060028014524534. 2014
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis
Lorente Fernández L; (...); Casanova-Estruch B
Article. 10.1016/j.nrl.2013.06.014. 2014
Control of Diabetes Mellitus in Liver Transplant Recipients
Ramos-Prol, Agustin; (...); Francisco Merino-Torres, Juan
Article. 2014
Diffuse Alveolar Hemorrhage as First Manifestation of a Pheochromocytoma
Querol Ripoll R; (...); Merino-Torres JF
Letter. 10.1016/j.arbres.2014.02.008. 2014
Drug Interaction Between Oral Cyclosporine Modified and Iron
Domingo-Chiva, E; (...); Poveda-Andres, JL
Article. 10.1177/1060028013514734. 2014
ECONOMIC IMPACT LINKED TO THE REDUCTION OF EXACERBATIONS WHEN A TREATMENT REGIME WITH INHALED ANTIBIOTICS IS SWITCHED TO AZTREONAM LYSINE IN PATIENTS WITH CYSTIC FIBROSIS AND CHRONIC PULMONARY INFECTION CAUSED BY PSEUDOMONAS AERUGINOSA
Sole A; (...); Casado MA
Meeting Abstract. 10.1016/j.jval.2014.08.1659. 2014
Estudio de utilizacion de boceprevir y telaprevir para el tratamiento de la hepatitis C cronica.
Marrero-Álvarez P; (...); Poveda-Andrés JL
Abstract of Published Item. 10.7399/FH.2014.38.1.1128. 2014
Genotype and Allele Frequencies of Drug-Metabolizing Enzymes and Drug Transporter Genes Affecting Immunosuppressants in the Spanish White Population
Bosó V; (...); Aliño SF
Article. 10.1097/FTD.0b013e3182a94e65. 2014
Incompatibility of undiluted busulfan injection with a needle-free valve
Cueto-Sola, M; (...); Poveda-Andres, JL
Letter. 10.2146/ajhp140111. 2014
Position statement: Hypoglycemia management in patients with diabetes mellitus. Diabetes Mellitus Working Group of the Spanish Society of Endocrinology and Nutrition
Mezquita-Raya, Pedro; (...); de la Torre Casares, Martin Lopez
Article. 2013
Prevalence of sarcopenia in a media and long stay Unit
Rubio-Maicas C; (...); Merino-Torres JF
Article. 10.1016/j.rce.2014.02.018. 2014
Research in sarcopenia: Importance of methodology. Reply
Rubio-Maicas C; (...); Merino-Torres JF
Letter. 10.1016/j.rce.2014.06.012. 2014
Single Nucleotide Polymorphisms, SNPs, Associated With the Efficacy and Security of Immunosuppressive Treatment in Heart Transplantation
Sanchez-Lazaro, I.; (...); Salvador-Sanz, A.
Article. 10.1016/j.healun.2014.01.392. 2014
SNPs and taxane toxicity in breast cancer patients
Bosó V; (...); Aliño SF
Article. 10.2217/PGS.14.127. 2014
Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature
Lizan, L; (...); Polanco, C
Review. 10.2147/PPA.S67253. 2014